Anastomotic bilio-biliary stricture after adult liver transplantation: A retrospective study over 20 years in a single center - 03/09/20
pages | 8 |
Iconographies | 2 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | Biliary complications, and especially anastomotic biliary strictures (ABS), are the main surgical complication after liver transplantation (LT). |
• | Incidence, risk factors, treatment and outcome of ABS in a large cohort (n=783) of adult LT recipients, with long follow-up are described. |
• | The overall incidence of ABS was 6.6%. Multivariate analysis disclosed that graft steatosis OR=6.262, 95%CI 1.936–20.257) and MELD score (OR=1.071, 95%CI 1.018–1.128) were significant risk factors for ABS. |
• | First-line treatment of ABS consisted in endoscopic stenting (88.0%). Recurrence of ABS after endoscopic treatment occurred in 24.0%. |
Summary |
Background |
Biliary complications are the main surgical complication after liver transplantation (LT). The aims of the present retrospective single center study were to describe anastomotic bilio-biliary strictures (ABS) in a large cohort of liver transplant recipients with long follow-up.
Methods |
All adult LT recipients who underwent a LT, with bilio-biliary anastomosis, between 1990 and 2010 in Edouard Herriot hospital, Lyon, France were included in the study.
Results |
The study population consisted in 783 patients (70.0% males), median age 50.5 years; main indication was alcohol-related liver disease (46.8%). The median follow-up after LT was 11.9 years (range 0–27 years). The overall incidence of anastomotic biliary complications was 9.7%: 50 patients developed an ABS (6.6%), after a median delay of 4.4 months (range 0.1–245.2) after LT and 32 (4.1%) developed biliary leakage after a median delay of 25 days (range 1–179). The actuarial risk of developing an ABS was 1.6% at 1-month, 2.7% at 3-months, 4.1% at 6-months, and 5.1%, 6.0%, 6.4%, 6.6%, 7.3% at 1-, 2-, 5-, 10- and 15-years, respectively. Univariate analysis disclosed that post-reperfusion syndrome and liver graft steatosis (≥30%) were significant risk factors for ABS. Multivariate analysis disclosed that graft steatosis (OR=6.262, 95%CI 1.936–20.257, P=0.002) and MELD score (OR=1.071, 95%CI 1.018–1.128, P=0.008) were significant risk factors for ABS. The first-line treatment of ABS consisted in endoscopic stenting for 44 patients (88.0%) and immediate success rate was 75.0%. Delayed recurrence of ABS occurred in 8/33 patients (24.0%).
Conclusion |
Our results suggest that steatotic grafts should be used for recipients without severe liver failure to avoid ABS, and that endoscopic stenting of post-LT ABS leads to a high success rate, but is associated with a significant risk of recurrence.
Le texte complet de cet article est disponible en PDF.Keywords : Liver transplantation, Biliary complications, Risk factors, Treatment, Outcome
Abbreviations : LT, ABS, ERCP
Plan
Vol 44 - N° 4
P. 564-571 - septembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?